View Author
scopus: 7004704760

Faggiano, A.

(Antongiulio Faggiano)


patient treatment cortisol cabergoline study cortisol levels serum microadenoma month level tumor cortisol secretion glucose cabergoline treatment disease diastolic blood pressure secretion endocrinol adenoma baseline /liter pressure blood cushing 20 patients insulin metab syndrome range fasting normalization macroadenoma dopamine effect effectiveness hypertension glucose tolerance tumor shrinkage mm hg fasting serum glucose tumor volume response agonist bromocriptine plasma cabergoline dose intolerance 0.002 pivonello serum prl urine collections glucose intolerance responsiveness diabetes mellitus diabetes dopamine agonist cabergoline volume table period tolerance index adenoma chromophobe adenoma body mass index systolic blood pressure heart rate prevalence diastolic homeostasis model result cortisol excretion january lombardi g radiological features radiological homa-ir collection finding homa-b value




2 Most Recent Publications

The medical treatment of Cushing's disease: Effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery (Article)
Pivonello, R. Martino, M.C. de Cappabianca, P. Leo, M. de Faggiano, A. Lombardi, G. Hofland, L.J. Lamberts, S.W.J. Colao, A.
2009-01-01
Dopamine receptor expression and function in corticotroph ectopic tumors. (Article)
Pivonello, R. Ferone, D. Herder, W.W. de Faggiano, A. Bodei, L. Krijger, R.R. de Lombardi, G. Colao, A. Lamberts, S.W.J. Hofland, L.J.
2007-01-01